v3.25.4
Schedule I - Condensed Financial Information of The Cigna Group - Statements of Cash Flows (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 18, 2025
Sep. 18, 2025
Jun. 18, 2025
Mar. 20, 2025
Dec. 19, 2024
Sep. 19, 2024
Jun. 20, 2024
Mar. 21, 2024
Dec. 21, 2023
Sep. 21, 2023
Jun. 22, 2023
Mar. 23, 2023
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from Operating Activities                              
Shareholders' net income                         $ 5,957 $ 3,434 $ 5,164
Adjustments to reconcile shareholders' net income to net cash provided by (used in) operating activities:                              
Net (gain) loss on sale of businesses                         (13) (24) 1,499
Other liabilities                         2,797 1,138 3,481
Other, net                         462 774 463
NET CASH PROVIDED BY OPERATING ACTIVITIES                         9,601 10,363 11,813
Cash Flows from Investing Activities                              
Net proceeds from short-term investments (purchased) sold                         (1,416) (1,309) (1,205)
NET CASH USED IN INVESTING ACTIVITIES                         (4,407) (2,102) (5,174)
Cash Flows from Financing Activities                              
Repayment of term loan                         2,000 0 0
Net proceeds on issuance of term loan                         1,999 0 0
Repayment of long-term debt                         (4,197) (3,000) (2,967)
Net proceeds on issuance of long-term debt                         4,458 4,462 1,491
Issuance of common stock                         203 305 187
Common stock dividend paid $ (396) $ (402) $ (401) $ (412) $ (384) $ (390) $ (392) $ (401) $ (358) $ (362) $ (362) $ (368) (1,611) (1,567) (1,450)
Repurchase of common stock                         (3,621) (7,034) (2,284)
Other, net                         (624) (349) (413)
NET CASH USED IN FINANCING ACTIVITIES                         (6,421) (7,647) (4,294)
Net (decrease) increase in cash, cash equivalents and restricted cash                         (1,195) 594 2,361
Cash, cash equivalents and restricted cash and cash equivalents January 1, [1]                         7,592 7,870  
Cash, cash equivalents and restricted cash, end of year (1) [1]                         7,736 7,592 7,870
The Cigna Group                              
Cash Flows from Operating Activities                              
Shareholders' net income                         5,957 3,434 5,164
Adjustments to reconcile shareholders' net income to net cash provided by (used in) operating activities:                              
Equity in income from subsidiaries                         (1,746) (4,154) (5,886)
Dividends received from subsidiaries                         1,171 2,916 1,381
Net (gain) loss on sale of businesses                         (4,890) 0 0
Other liabilities                         496 (306) 540
Other, net                         592 243 640
NET CASH PROVIDED BY OPERATING ACTIVITIES                         1,580 2,133 1,839
Cash Flows from Investing Activities                              
Proceeds from divestiture of businesses                         4,891 0 0
NET CASH USED IN INVESTING ACTIVITIES                         4,891 0 622
Cash Flows from Financing Activities                              
Net change in commercial paper                         (880) (357) 1,237
Repayment of term loan                         (2,000) 0 0
Net proceeds on issuance of term loan                         1,999 0 0
Repayment of long-term debt                         (3,861) (2,731) (2,822)
Net proceeds on issuance of long-term debt                         4,458 4,462 1,491
Issuance of common stock                         203 305 187
Common stock dividend paid                         (1,611) (1,567) (1,450)
Repurchase of common stock                         (3,621) (7,034) (2,284)
Other, net                         (108) (117) (110)
NET CASH USED IN FINANCING ACTIVITIES                         (6,522) (2,278) (2,278)
Net (decrease) increase in cash, cash equivalents and restricted cash                         (51) (145) 183
Cash, cash equivalents and restricted cash and cash equivalents January 1,                         190 335 152
Cash, cash equivalents and restricted cash, end of year (1)                         139 190 335
The Cigna Group | Subsidiaries                              
Cash Flows from Investing Activities                              
Net change in amounts due from affiliates                         0 0 622
Cash Flows from Financing Activities                              
Net change in amounts due to/from affiliates                         (1,101) 4,761 1,473
Net amounts due from affiliates settled through capital transactions                         $ (1,617) $ (7,565) $ (5,221)
[1] Restricted cash and cash equivalents were reported in other long-term investments and Other assets.